These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11585186)

  • 1. Pharmaceutical cost control in Canada: does it work?
    Menon D
    Health Aff (Millwood); 2001; 20(3):92-103. PubMed ID: 11585186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug spending in Canada: recent trends and causes.
    Morgan S
    Med Care; 2004 Jul; 42(7):635-42. PubMed ID: 15213487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whither seniors' pharmacare: lessons from (and for) Canada.
    Morgan SG; Barer ML; Agnew JD
    Health Aff (Millwood); 2003; 22(3):49-59. PubMed ID: 12757272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Northeast states pursue price controls to stop rise in prescription drug costs.
    Carlson B
    Manag Care; 2000 May; 9(5):12-3. PubMed ID: 11185259
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical policies in Canada: another example of federal-provincial discord.
    Anis AH
    CMAJ; 2000 Feb; 162(4):523-6. PubMed ID: 10701389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain.
    Moreno-Torres I; Puig-Junoy J; Raya JM
    Eur J Health Econ; 2011 Dec; 12(6):563-73. PubMed ID: 20809092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Points to consider about prescription drug prices: an overview of federal policy and pricing studies.
    Kucukarslan S; Hakim Z; Sullivan D; Taylor S; Grauer D; Haugtvedt C; Zgarrick D
    Clin Ther; 1993; 15(4):726-38. PubMed ID: 8221823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical price controls at the state level.
    Kozma CM
    Manag Care Interface; 2001 Jul; 14(7):59-60. PubMed ID: 11481818
    [No Abstract]   [Full Text] [Related]  

  • 10. European healthcare policies for controlling drug expenditure.
    Ess SM; Schneeweiss S; Szucs TD
    Pharmacoeconomics; 2003; 21(2):89-103. PubMed ID: 12515571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of a national prescription drug formulary on prices, market share, and spending: lessons for Medicare?
    Huskamp HA; Epstein AM; Blumenthal D
    Health Aff (Millwood); 2003; 22(3):149-58. PubMed ID: 12757279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacists want to assume penalty].
    MMW Fortschr Med; 2006 May; 148(20):55. PubMed ID: 16805194
    [No Abstract]   [Full Text] [Related]  

  • 13. [Barmer reimbursement insurance pays pharmacists a fee for monitoring physicians. Pharmacists now control their prescriptions!].
    Schmidt K
    MMW Fortschr Med; 2004 May; 146(21):55-6. PubMed ID: 15373087
    [No Abstract]   [Full Text] [Related]  

  • 14. Government commitment and regulation of prescription drugs.
    Frank RG
    Health Aff (Millwood); 2003; 22(3):46-8. PubMed ID: 12757271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug costs should be lower. Hessian colleagues beaten without compassion].
    MMW Fortschr Med; 2004 Jul; 146(27-28):49. PubMed ID: 15526667
    [No Abstract]   [Full Text] [Related]  

  • 16. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference pricing for drugs: is it compatible with U.S. health care?
    Kanavos P; Reinhardt U
    Health Aff (Millwood); 2003; 22(3):16-30. PubMed ID: 12757268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
    Openshaw MS
    Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opinion: price controls on prescription drugs.
    Franks B
    N J Med; 2004 Apr; 101(4):56, 55. PubMed ID: 15103791
    [No Abstract]   [Full Text] [Related]  

  • 20. Managing psychotropic drug costs: will formularies work?
    Huskamp HA
    Health Aff (Millwood); 2003; 22(5):84-96. PubMed ID: 14515884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.